Navigation Links
AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment
Date:10/20/2009

VIENNA, Austria, October 20 /PRNewswire/ -- AFFiRiS AG today announced that the primary endpoints have been met for the Phase I clinical studies of its two Alzheimer's vaccines AD01 and AD02, which demonstrated favourable safety and tolerability profiles. These results trigger a 10 million EUR milestone payment from licensee GlaxoSmithKline Biologicals.

All 48 patients treated in these studies were given four vaccinations which were well tolerated and no serious side effects associated with the vaccine candidates were observed.

The results demonstrate the potential value of the AFFITOME(R) technology, which forms the platform for both of these vaccines and could result in a generation of highly specific vaccines. While analysing the clinical outcome in detail the company, together with GSK Biologicals is progressing to the next development stage. AFFiRiS AG is also using AFFITOME(R) technology to develop vaccines for Parkinson's disease, atherosclerosis and four other indications.

Affinity to Success

Commenting on the results, AFFiRiS' CEO, Dr. Walter Schmidt, said: "This initial demonstration of safety and tolerability is an outstanding milestone in our joint efforts with GSK Biologicals to develop a therapeutic Alzheimer's vaccination. However, the results also highlight the potential capability of our AFFITOME(R) technology, which forms the basis for the two vaccine candidates. This technology is also the platform for our six other vaccine programmes, including Parkinson's and atherosclerosis currently under development. The results not only represent an important milestone in the development of our Alzheimer's vaccination but also confirm our basic strategy. We will be investing all of this milestone payment in our research and development projects."

In October 2008 AFFiRiS concluded a licensing agreement with GSK Biologicals on jointly developing the Alzheimer's vaccin
'/>"/>

SOURCE AFFiRis AG
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. AFFiRiS Begins Development of a Parkinsons Vaccine
2. AFFiRiS: Milestone Reached in Clinical Trial of Alzheimers Vaccine
3. NKTR-102 Shows Encouraging Anti-Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplinary Congress
4. Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
5. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
6. Encouraging Gene Therapy Results in Genetic Form of Blindness
7. Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO
8. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
9. PTC Therapeutics Presents Encouraging Phase 1 Results of its Novel VEGF Inhibitor, PTC299, at 30th Annual San Antonio Breast Cancer Symposium
10. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
11. New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... 11 On March 10-11, 2010 , the Joint Advisory ... Drugs and the Drug Safety and Risk Management Advisory Committees -- discussed the ... including SYMBICORT ® (budesonide/formoterol fumarate dihydrate). , ... ... ...
(Date:3/11/2010)... , March 11 SiteJabber.com , a leading consumer ... LegitScript.com , the world,s largest online pharmacy verification program, have announced a ... fraudulent ones. , ... ... , ...
(Date:3/11/2010)... Health , a leading healthcare-focused global consultancy and marketing insights company, today announced ... discussion at the Pharmaceutical Marketing Research Group,s (PMRG) 2010 Annual National Conference. The ... in Orlando, Florida . , ... ... ...
Breaking Medicine Technology:AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 2AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 3AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 4AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 5AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 6AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 7AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma 8SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 2SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies 3Kantar Health CEO to Participate in Panel Discussion at PMRG 2010 Annual National Conference 2Kantar Health CEO to Participate in Panel Discussion at PMRG 2010 Annual National Conference 3Kantar Health CEO to Participate in Panel Discussion at PMRG 2010 Annual National Conference 4North Highland Ranks in Top Five of Consulting Industrys Best Firms to Work For 14490 1North Highland Ranks in Top Five of Consulting Industrys Best Firms to Work For 14490 2ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 1ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 2ISMPP Supports Best Practices and Transparency in Medical Publications 3A Better Understanding of Terms Such as Ghostwriting Needed 14486 3GHX Health ConneXion 28TM 29 Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption 5516 1GHX Health ConneXion 28TM 29 Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption 5516 2GHX Health ConneXion 28TM 29 Data Pool Gains Momentum as Healthcare Industry Moves Toward Standards Adoption 5516 3
... The demand for medical devices,has been increasing in ... devices is so high because local manufacturers concentrate ... equipment in most,Russian hospitals and clinics are obsolete ... very attractive also for foreign manufacturers. , ...
... 31 The Kroger Co. (NYSE: KR ) ... cookies and select cakes sold in its family of stores ... Salmonella. Stores under the following names in the 31 states ... Ralphs, Fred Meyer, Food 4 Less, Fry,s, King Soopers, Smith,s, ...
Other Medicine Technology:Foreign Medical Devices are in High Demand in Russia 2Foreign Medical Devices are in High Demand in Russia 3Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 2Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk 3
(Date:3/13/2010)... March 13 The American Association of Public Health Physicians submitted ... in response to their official stance concerning electronic cigarettes . They ... health the products could have in the future. , ... ... ...
(Date:3/13/2010)... a new report from The Digital Policy Council, examines how Web ... Government 2.0 where politics has a ‘human’ face and political views ... , ... Washington, DC (PRWeb) March 13, 2010 -- Real ... state around the world are using the World Wide Web to ...
(Date:3/13/2010)... professional and collegiate hockey players had abnormal hip and ... no symptoms of injury, according to a study presented ... Specialty Day in New Orleans, (March 13). The study,s ... to not depend excessively on imaging when diagnosing patients. ... MRI results are found incidentally in active roster hockey ...
(Date:3/12/2010)... , March 12 For Southern California residents who are looking ... as obese, who have a BMI of over 40, are prime candidates for Lap Band ... and gastric bypass surgery can lose anywhere from ten to twenty five pounds of ... ... ...
(Date:3/12/2010)... Tenn. , March 12 ... CYH ), its chairman, president and chief ... executive vice president and chief financial officer, ... Institutional Investor magazine as the number one ... the healthcare and managed care sectors. This is ...
Breaking Medicine News(10 mins):Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 2Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 3Health News:Electronic Cigarettes Are Tobacco Products, States AAPHP 4Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 2Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 3Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 4Health News:Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net 5Health News:New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs 2Health News:Dr. Feiz (drfeiz.com) Asks: What Is Better for You? Lap Band Surgery/Realize Band Surgery or Gastric Bypass Surgery 2Health News:Dr. Feiz (drfeiz.com) Asks: What Is Better for You? Lap Band Surgery/Realize Band Surgery or Gastric Bypass Surgery 3Health News:Community Health Systems, Inc.'s Wayne T. Smith and Larry Cash Named America's Top Healthcare CEO and CFO 2
... BRUNSWICK, N.J., Sept. 28 James M.,Golubieski, president ... the company has made a $500,000 commitment to ... Medicine & Dentistry of New Jersey,(UMDNJ) committed to ... scientific officer of CellXplore and,professor in the Department ...
... Will Reduce Cost Increases by $94 ... Million ... announced changes to the commonwealth Retired,Employees Health Program (REHP) that will preserve ... "Rising health care costs are one of the greatest challenges facing,employers across ...
... Biotech and Pharma Practice, CHICAGO, Sept. 28 ... property law firms in the U.S., is pleased to,announce ... the,addition of four experienced patent attorneys from Pfizer, Inc. ... and experience to our,group," said Jeffery M. Duncan, chair ...
... at the Kimmel Cancer Center at Jefferson in Philadelphia ... the hormone prolactin in breast cancer. They have found ... development and milk production, initiates a new signaling pathway ... cancer cells. , The work, which appears this ...
... 28 The landscape of scientific,publications strategy, planning ... guidelines. Half of global publications groups are fully,located ... to see a,shift to medical groups to diminish ... Best Practices, LLC,s Business Excellence,Board (BEB). In ...
... is pleased to,announce that it has once again ... for Washington State, a ranking of the 50 ... in the,area by Deloitte & Touche LLP, one ... is privately held, ranked 27th,on the list with ...
Other Medicine News:Health News:Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 3Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 4Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 5Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 6Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 7Health News:Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione 2Health News:Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione 3Health News:Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer 2Health News:Scientific Publications Strategy & Delivery Shifts from Marketing to Medical 2Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 2Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 3Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 4
Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis...
Family Practice: Letter Acuity, Astigmatic,Clock, Tumbling E, and Allen Tests....
Coat-A-Count PSA IRMA is an,immunoradiometric assay intended for the,quantitative measurement of,prostate-specific antigen (PSA) in serum,to aid in the management of prostate,cancer patient...
Stereo Smile II also includes a blank card and tests,at 60, 120, 240 and 480 sec of arc., ,Smile Test II Includes:, 1 demonstration card, 1 pair pediatric 3-D viewers, 1 pair infant 3-D v...
Medicine Products: